| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 01/07/2004 | CN1133417C Method of regulating skin appearance with vitamin B3 compound |
| 01/06/2004 | US6675105 Structure-based identification of candidate compounds using three dimensional structures and models of Fc receptors |
| 01/06/2004 | US6673968 Method of producing n-(4,5-bis-methanesulfonyl-2-methyl-benzoyl)-guanidine, the hydrochloride thereof |
| 01/06/2004 | US6673935 making a Form V polymorph of etoricoxib |
| 01/06/2004 | US6673931 (4-(4-(3-(2-methoxy-benzyloxy)-propoxy)-phenyl)-5-(4-methoxy -naphthalen-2-ylmethoxy)-piperidin-3-yl)-methanol for example; use treating restenosis, glaucoma, cardiac and kidney insufficiency |
| 01/06/2004 | US6673927 Farnesyl transferase inhibitors |
| 01/06/2004 | US6673903 Antiproliferative agents |
| 01/06/2004 | US6673897 Inhibitors of NF-κB Activation |
| 01/06/2004 | US6673895 Pro-apoptotic fragments of the dengue virus envelope glycoproteins |
| 01/06/2004 | US6673838 Succinate salt of O-desmethyl-venlafaxine |
| 01/06/2004 | US6673825 Urazole compounds useful as anti-inflammatory agents |
| 01/06/2004 | US6673813 Methods for identifying and treating resistant tumors |
| 01/06/2004 | US6673812 Administering effective amount of compound having rho kinase inhibitory activity |
| 01/06/2004 | US6673807 Administering compound possessing inhibitory activity on production of nitric oxide and tricyclic macrolide or salt, solvate or hydrate thereof to increase graft survival time in transplantation subject |
| 01/06/2004 | US6673803 Quinazoline derivatives and pharmaceutical compositions containing them |
| 01/06/2004 | US6673798 PDGF receptor kinase inhibitory compounds, their preparation, purification and pharmaceutical compositions including same |
| 01/06/2004 | US6673797 Cyclooxygenase-2 inhibitors; treating inflammatory disease induced by cyclooxygenase-2 |
| 01/06/2004 | US6673796 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| 01/06/2004 | US6673795 Pyrimidine, pyrazine and triazane derivatives |
| 01/06/2004 | US6673789 2-pyridinylguanidine urokinase inhibitors |
| 01/06/2004 | US6673787 Pyrimidinesulfonamide containing indole compounds used as antiangiogenic and antitumor agents |
| 01/06/2004 | US6673768 Transgenic animal models for cardiac hypertrophy and methods of use thereof (treating) |
| 01/06/2004 | US6673609 Diagnosing anemia |
| 01/06/2004 | US6673604 Muscle cells and their use in cardiac repair |
| 01/06/2004 | US6673555 Methods of using SCAP antagonists |
| 01/06/2004 | US6673379 Use of non-alkalized cocoa solids in a drink |
| 01/06/2004 | US6673377 Extracts derived from Pueraria mirifica, Butea superba and/or Mucuna collettii and extraction thereof |
| 01/06/2004 | US6673370 Oxidized collagen formulations for use with non-compatible pharmaceutical agents |
| 01/06/2004 | US6673341 Inhibiting transforming growth factor (tgf-beta) mediated angiogenesis, thereby inhibiting the proliferative disease in vertebrate |
| 01/06/2004 | US6673336 Comprising an inorganic pigment and an active substance based on organic compounds being covalently bound through a group 3b,4a,4b,5b,6b spacer group to the inorganic pigment; sunscreen agents |
| 01/06/2004 | CA2301990C New substitute dimerized derivatives, process for preparing them, and pharmaceutical compounds containing them |
| 01/06/2004 | CA2293712C Benzo(5,6)cycloheptapyridine cyclic ureas and lactams useful as farnesyl protein transferase inhibitors |
| 01/06/2004 | CA2253870C Inhibition of matrix metalloproteases by substituted phenalkyl compounds |
| 01/06/2004 | CA2247063C Treatment of macular edema |
| 01/06/2004 | CA2145248C Pharmaceutical compositions containing time-released orally taken trimetazidine |
| 01/06/2004 | CA2128208C Novel seven transmembrane receptors |
| 01/06/2004 | CA2086681C Growth promoting agent derived from milk |
| 01/02/2004 | EP1375520A1 Apoptosis induced by monoclonal antibody anti-Her2 |
| 01/02/2004 | EP1375519A2 Method for affecting cellular function using antibodies |
| 01/02/2004 | EP1375518A1 Anti-osteopontin antibody and use thereof |
| 01/02/2004 | EP1375503A1 Dioxino derivatives and their use as dopanine agonists |
| 01/02/2004 | EP1375496A1 N-aryl-substituted cyclic amine derivative and medicine containing the same as active ingredient |
| 01/02/2004 | EP1375489A1 Medicinal composition containing 1,3-thiazine derivative |
| 01/02/2004 | EP1375486A1 Nitrogen-containing heteroaryl compounds having hiv integrase inhibitory activity |
| 01/02/2004 | EP1375484A1 Carboxylic acids |
| 01/02/2004 | EP1375482A1 Benzamidine derivative |
| 01/02/2004 | EP1375472A1 Benzene compound and salt thereof |
| 01/02/2004 | EP1375465A1 Cyclooctanone derivative and cyclodecanone derivative, and use thereof |
| 01/02/2004 | EP1375434A1 Method and device for manufacturing advanced water containing ultra-fine gold particles |
| 01/02/2004 | EP1374908A2 Polymer-drug conjugates comprising hydrazide linkers |
| 01/02/2004 | EP1374907A2 Drug transport and delivery system |
| 01/02/2004 | EP1374902A1 Remedies for inflammatory bowel diseases |
| 01/02/2004 | EP1374899A1 Remedies for post-traumatic stress disorder |
| 01/02/2004 | EP1374891A1 Method for accelerating the rate of mucociliary clearance |
| 01/02/2004 | EP1374889A1 Method of inducing angiogenesis by micro-organs |
| 01/02/2004 | EP1374888A1 Remedies for arthritis deformans and remedies for rheumatoid arthritis |
| 01/02/2004 | EP1374885A1 Use of at least one peptide of alpha-s2 casein with inhibiting activity of ACE for the preparation of medicaments and foodstuffs |
| 01/02/2004 | EP1374876A1 Method of treating tumor and consignment system of proliferating and processing activated lymphocytes to be used in parallel to pdt |
| 01/02/2004 | EP1374872A1 Pharmaceutical preparations comprising a combination of at least one representative of antibiotics and one of antiphlogistics, process for manufacturing, and use thereof |
| 01/02/2004 | EP1374869A1 Novel use of arylethene sulfonamide derivative |
| 01/02/2004 | EP1374867A1 Use of chloroquine, hydroxychloroquine and 4 amino-quinolinic derivatives to obtain a drug for the anti retroviral therapy, active towards hiv sensitive strains and towards hiv strains which are resistant to both nucleosidic and non-nucleosidic reverse transcriptase inhibitors and to proteases inhibitors |
| 01/02/2004 | EP1374865A1 Use of R,S-(+/-)-alpha-lipoic acid, R(+)-alpha-lipoic acid or S-(-)-alpha-lipoic acid in reduced or oxidised form, or their metabolites as well as their salts, esters or amides, for the treatment of hearing disorders |
| 01/02/2004 | EP1374862A2 Use of a substance influencing the degree of phosphorylation of BAD for the treatment of atherosclerosis |
| 01/02/2004 | EP1374853A1 Cosmetic and/or dermatological composition containing at least one oxidation-sensitive hydrophilic active stabilised by at least one polymer or copolymer of maleic anhydride |
| 01/02/2004 | EP1374852A1 Cosmetic and/or dermatological Composition containing at least one oxidation-sensitive hydrophilic active stabilised by at least one polymer or copolymer of maleic anhydride |
| 01/02/2004 | EP1374851A1 Cosmetic and/or dermatological use of a composition containing at least one oxidation-sensitive hydrophilic active stabilised by at least one polymer or copolymer of maleic anhydride |
| 01/02/2004 | EP1374850A1 Cosmetic and/or dermatological composition containing at least one oxidation-sensitive hydrophilic active stabilised by at least one polymer or copolymer of maleic anhydride |
| 01/02/2004 | EP1374849A1 Cosmetic and/or dermatological use of a composition containing at least one oxidation-sensitive hydrophilic active stabilised by at least one polymer or copolymer of maleic anhydride |
| 01/02/2004 | EP1373888A2 Method for screening for progesterone receptor isoform-specific ligands |
| 01/02/2004 | EP1373554A2 Modulators of bruton's tyronsine kinase, their identification and use |
| 01/02/2004 | EP1373543A2 Method for producing pectin hydrolysis products |
| 01/02/2004 | EP1373535A2 Improved gene expression |
| 01/02/2004 | EP1373517A2 Human kinases |
| 01/02/2004 | EP1373516A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins and uses thereof |
| 01/02/2004 | EP1373504A2 Mammalian tribbles signaling pathways and methods and reagents related thereto |
| 01/02/2004 | EP1373502A2 Dopaminergic neuronal survival-promoting factors and uses thereof |
| 01/02/2004 | EP1373489A2 Human dual specificity protein phosphatase 7-like protein |
| 01/02/2004 | EP1373368A1 Compounds for a controlled release of active compounds |
| 01/02/2004 | EP1373317A2 Nuclear hormone receptor ligand binding domains |
| 01/02/2004 | EP1373316A2 Nuclear hormone receptor ligand binding domain |
| 01/02/2004 | EP1373315A2 Nuclear hormone receptor ligand binding domain |
| 01/02/2004 | EP1373313A2 Proteins and nucleic acids encoding same |
| 01/02/2004 | EP1373306A2 Cytoskeletion-associated proteins |
| 01/02/2004 | EP1373289A1 9-amino-14-membered macrolide derived from leucomycin |
| 01/02/2004 | EP1373271A1 Indole derivatives having an inhibitory effect on protein kinases |
| 01/02/2004 | EP1373269A1 Jun kinase inhibitors |
| 01/02/2004 | EP1373267A2 Non-nucleoside reverse transcriptase inhibitors |
| 01/02/2004 | EP1373266A2 (diazolo-pyridinyl)-pyrimidines for use in treatment of cns disorders and diabetes |
| 01/02/2004 | EP1373265A1 Substituted 2,6-diamino-3,5-dicyano-4-aryl-pyridines and their use as adenosine receptor-selective ligands |
| 01/02/2004 | EP1373264A1 3-heterocyclylpropanohydroxamic acid as procollagen c-proteinase inhibitors |
| 01/02/2004 | EP1373263A1 Heterocyclic compounds for aging-related and diabetic vascular complications |
| 01/02/2004 | EP1373262A2 Azacycloalkyl substituted acetic acid derivatives for use as mmp inhibitors |
| 01/02/2004 | EP1373261A2 Cyclopropaheterocycles as non-nucleoside reverse transcriptase inhibitors |
| 01/02/2004 | EP1373259A1 Pyridazinone aldose reductase inhibitors |
| 01/02/2004 | EP1373258A1 Ether derivatives useful as inhibitors of pde4 isozymes |
| 01/02/2004 | EP1373257A1 Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases |
| 01/02/2004 | EP1373256A1 Ccr5 antagonists useful for treating aids |
| 01/02/2004 | EP1373253A1 Inhibitors of cyclin dependent kinases as anti-cancer agent |
| 01/02/2004 | EP1373252A1 Chemical derivatives and their use as anti-telomerase agent |
| 01/02/2004 | EP1373251A2 Non-imidazole compounds as histamine h3 antagonists |